TipRanks
Shandong Xinhua Pharmaceutical Company Limited Class H (DE:XIN)
FRANKFURT:XIN
Germany Market
XIN
Shandong Xinhua Pharmaceutical Company Limited Class H
RESEARCH TOOLSreports

Shandong Xinhua Pharmaceutical Company Limited Class H (XIN) Stock News & Sentiment

2 Followers
Shandong Xinhua Pharma Proposes Board Appointment of Senior Economist Liu Weimin
Premium
Company Announcements
Shandong Xinhua Pharma Proposes Board Appointment of Senior Economist Liu Weimin
43m ago
Xinhua Pharmaceutical Wins Approval for Sacubitril Valsartan Tablets in China
Premium
Company Announcements
Xinhua Pharmaceutical Wins Approval for Sacubitril Valsartan Tablets in China
1d ago
Shandong Xinhua Subsidiary Wins Approval for Donepezil Orally Disintegrating Tablets in China
Premium
Company Announcements
Shandong Xinhua Subsidiary Wins Approval for Donepezil Orally Disintegrating Tablets in China
21d ago
Shandong Xinhua Pharmaceutical Wins Approval for New Oral Solution
Premium
Company Announcements
Shandong Xinhua Pharmaceutical Wins Approval for New Oral Solution
21d ago
Shandong Xinhua Pharma Wins Approval for Levocarnitine Oral Solution
Premium
Company Announcements
Shandong Xinhua Pharma Wins Approval for Levocarnitine Oral Solution
21d ago
Shandong Xinhua Subsidiary Wins Key Generic Consistency Approval for Azithromycin
Premium
Company Announcements
Shandong Xinhua Subsidiary Wins Key Generic Consistency Approval for Azithromycin
1M ago
Shandong Xinhua Wins NMPA Approval for Dapoxetine Tablets
Premium
Company Announcements
Shandong Xinhua Wins NMPA Approval for Dapoxetine Tablets
1M ago
More DE:XIN News >

XIN News on the Web

Xinhua Pharmaceutical Wins China Approval for Dapagliflozin Tablets
TipRanks News
Bullish
Xinhua Pharmaceutical Wins Approval to Begin Clinical Trials for Novel Pain Drug LXH-2103
TipRanks News
Bullish
Shandong Xinhua Pharmaceutical Sets AGM to Review 2025 Results and Governance Changes
TipRanks News
Neutral
Shandong Xinhua Pharmaceutical Wins NMPA Approval for Bumetanide Injection
TipRanks News
Neutral
Shandong Xinhua Pharma Sets Board Meeting to Review Q1 2026 Results
TipRanks News
Neutral
Xinhua Pharmaceutical Wins NMPA Approval for New Electrolyte Injection
TipRanks News
Bullish
Xinhua Pharmaceutical Wins Approval to Take Over Galculus Bovis and Metronidazole Capsule Rights
TipRanks News
Bullish
Shandong Xinhua Pharmaceutical Announces Retirement of Non-Executive Director
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
DE:XIN
Sector Average
Media Buzz
This Week1 articles
Weekly Average0.75 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:XIN’s Media Buzz Sentiment?
1 articles about DE:XIN were published this week. In an average week, 0.75 articles are published.
    What is DE:XIN’s weekly average amount of articles?
    In an average week, 0.75 articles about DE:XIN are published.
      What is DE:XIN’s News Sentiment?
      100% of articles about DE:XIN were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        AMGNAmgen
        MCKMcKesson
        ONCBeOne Medicines
        NVSNovartis
        NTRANatera
        Showing the stocks with the most bullish news sentiment over the past week